GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,315 | +32.4% | 630,662 | +58.8% | 0.02% | +33.3% |
| Q2 2023 | $23,648 | -65.6% | 397,203 | -67.3% | 0.02% | -53.1% |
| Q1 2023 | $68,710 | +7094.8% | 1,213,115 | +9332.5% | 0.03% | – |
| Q4 2022 | $955 | -99.9% | 12,861 | -34.0% | 0.00% | -100.0% |
| Q3 2022 | $1,161,000 | -19.7% | 19,495 | -24.3% | 0.00% | 0.0% |
| Q2 2022 | $1,446,000 | -0.8% | 25,753 | +30.3% | 0.00% | 0.0% |
| Q1 2022 | $1,458,000 | -46.4% | 19,769 | -47.5% | 0.00% | 0.0% |
| Q4 2021 | $2,718,000 | -60.7% | 37,656 | -58.2% | 0.00% | -66.7% |
| Q3 2021 | $6,910,000 | +85.6% | 90,185 | +87.7% | 0.00% | +50.0% |
| Q2 2021 | $3,724,000 | +344.4% | 48,046 | +253.7% | 0.00% | – |
| Q1 2021 | $838,000 | -88.3% | 13,582 | -87.6% | 0.00% | -100.0% |
| Q4 2020 | $7,152,000 | +22.7% | 109,663 | -6.9% | 0.00% | +33.3% |
| Q3 2020 | $5,831,000 | +242.4% | 117,740 | +230.2% | 0.00% | +200.0% |
| Q2 2020 | $1,703,000 | +5.0% | 35,661 | -6.6% | 0.00% | 0.0% |
| Q1 2020 | $1,622,000 | -69.9% | 38,173 | -58.3% | 0.00% | -66.7% |
| Q4 2019 | $5,397,000 | +22.1% | 91,651 | +6.0% | 0.00% | 0.0% |
| Q3 2019 | $4,420,000 | -34.9% | 86,464 | -46.1% | 0.00% | -25.0% |
| Q2 2019 | $6,790,000 | +204.2% | 160,485 | +255.2% | 0.00% | +100.0% |
| Q1 2019 | $2,232,000 | -46.4% | 45,183 | -53.1% | 0.00% | -33.3% |
| Q4 2018 | $4,167,000 | +8.5% | 96,290 | +42.3% | 0.00% | 0.0% |
| Q3 2018 | $3,840,000 | -41.4% | 67,659 | -47.9% | 0.00% | -40.0% |
| Q2 2018 | $6,549,000 | +289.1% | 129,786 | +284.3% | 0.01% | +400.0% |
| Q1 2018 | $1,683,000 | +35.0% | 33,770 | +11.3% | 0.00% | 0.0% |
| Q4 2017 | $1,247,000 | +26.0% | 30,349 | -8.9% | 0.00% | 0.0% |
| Q3 2017 | $990,000 | -37.2% | 33,313 | -29.9% | 0.00% | -50.0% |
| Q2 2017 | $1,577,000 | +215.4% | 47,535 | +181.6% | 0.00% | +100.0% |
| Q1 2017 | $500,000 | -89.1% | 16,880 | -90.9% | 0.00% | -80.0% |
| Q4 2016 | $4,595,000 | +492.1% | 185,216 | +438.5% | 0.01% | +400.0% |
| Q3 2016 | $776,000 | +101.0% | 34,392 | +112.3% | 0.00% | 0.0% |
| Q2 2016 | $386,000 | -83.6% | 16,202 | -84.2% | 0.00% | -75.0% |
| Q1 2016 | $2,354,000 | +706.2% | 102,337 | +848.1% | 0.00% | – |
| Q4 2015 | $292,000 | +5.8% | 10,794 | -21.7% | 0.00% | – |
| Q3 2015 | $276,000 | -19.3% | 13,793 | +1.1% | 0.00% | – |
| Q2 2015 | $342,000 | +598.0% | 13,645 | +588.4% | 0.00% | – |
| Q1 2015 | $49,000 | -43.0% | 1,982 | -47.1% | 0.00% | – |
| Q4 2014 | $86,000 | +104.8% | 3,747 | +67.4% | 0.00% | – |
| Q3 2014 | $42,000 | +35.5% | 2,238 | +66.8% | 0.00% | – |
| Q2 2014 | $31,000 | -47.5% | 1,342 | -40.3% | 0.00% | – |
| Q1 2014 | $59,000 | -92.7% | 2,247 | -94.4% | 0.00% | -100.0% |
| Q4 2013 | $804,000 | +466.2% | 40,165 | +381.4% | 0.00% | – |
| Q3 2013 | $142,000 | +189.8% | 8,344 | +186.7% | 0.00% | – |
| Q2 2013 | $49,000 | – | 2,910 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 373,254 | $26,949,000 | 17.58% |
| Next Capital Management LLC | 111,098 | $8,021,000 | 5.42% |
| Sterling Investment Advisors, Ltd. | 188,123 | $13,582,000 | 3.82% |
| Integral Health Asset Management, LLC | 180,000 | $12,996,000 | 3.60% |
| Pembroke Management, LTD | 602,447 | $43,497,000 | 3.19% |
| Godshalk Welsh Capital Management, Inc. | 73,435 | $5,302,000 | 3.02% |
| XXEC, Inc. | 51,925 | $3,420,000 | 2.92% |
| Sivik Global Healthcare LLC | 75,000 | $5,415,000 | 2.32% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 654,100 | $47,226,000 | 2.11% |
| Van Berkom & Associates Inc. | 929,856 | $67,136,000 | 1.98% |